Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review
- 31 May 2019
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 20 (6), E313-E326
- https://doi.org/10.1016/S1470-2045(19)30177-9
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trialEuropean Journal Of Cancer, 2013
- Neutrophil extracellular traps sequester circulating tumor cells and promote metastasisJCI Insight, 2013
- Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation gradeBMC Cancer, 2013
- Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression and Survival in Operable Squamous-Cell Laryngeal CancerPLOS ONE, 2013
- Podoplanin and E-cadherin Expression in Preoperative Incisional Biopsies of Oral Squamous Cell Carcinoma Is Related to Lymph Node MetastasesInternational Journal of Surgical Pathology, 2013
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune EscapeScience Translational Medicine, 2012
- Polycomb group protein EZH2‐mediated E‐cadherin repression promotes metastasis of oral tongue squamous cell carcinomaMolecular Carcinogenesis, 2011
- Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerThe New England Journal of Medicine, 2010
- REporting recommendations for tumour MARKer prognostic studies (REMARK)European Journal of Cancer, 2005